Meeting Banner
Abstract #0739

Effects of an Antidepressant Dose of Ketamine on Prefrontal Aspartate, Glutamine and Gaba Levels in Healthy Subjects: Assessing the Post-Infusion Interval with 1H-MRS

Milan Scheidegger1, 2, Alexander Fuchs1, Mick Lehmann2, Simone Grimm2, 3, Heinz Boeker2, Erich Seifritz2, Anke Henning1, 4

1Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland; 2Clinic of Affective Disorders and General Psychiatry, University Hospital of Psychiatry Zurich, Zurich, Switzerland; 3Cluster Languages of Emotion, Freie Universitt Berlin, Berlin, Germany, Germany; 4Max Planck Institute for Biological Cybernetics, Tbingen, Germany

Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at subanaesthetic doses, thus providing a valuable research tool for the investigation of the neurobiology of major depressive disorder (MDD). This double-blind, randomized, placebo-controlled 1H-MRS study in 13 healthy subjects reveals the neuropharmacological effects of a single intravenous subanaesthetic ketamine infusion on prefrontal aspartate, glutamine and GABA levels in the 3-4 hour post-infusion interval. Our findings are in line with a shift in the excitatory-inhibitory balance following ketamine administration that may play an important role in restoring parts of the disrupted neurometabolic homeostasis in MDD patients.

Abstract PDF Presentation Video

Keywords

accessible administered administration aimed altered antagonism anterior antidepressant approximately assessed bilateral bingen biological biomedical blind blood body brain build challenge clinic clinical cluster complements completed concentrations conditions consciousness considered continuous controlled cortex decrease decreased deficit details dimensional discovery disrupted dose double drug duration either elevated emerged emotion energy engineering especially excitatory excluded experimental finding findings general glucose glutamate healthy henning history homeostasis hour human impaired important increasing indicating infusion inhibitory institute interestingly interval intravenous involved items knowledge languages major marker mediators metabolism metabolite metabolites minutes modulation mostly neurological novel observe overall oxidative paired pairwise pathways patients pharmacological placebo placement play poor population positive post potential previous psychiatric psychiatry putative randomized rapid rating receive receptor reduced regulation release relevant report reported reports represent resolved response scale score separate session sessions severity side significantly simultaneous spectral spectroscopy starts statistical stimulated subgroup subjects suggesting system target targeting terms treatment trend unambiguous unit usually volume